Personal and environmental characteristics related to epithelial ovarian cancer: Reproductive and menstrual events and oral contraceptive use

American Journal of Epidemiology

Volumn 128, Issue 6, 1988, Pages 1216-1227

  Wu, Marion L ^a   Whittemore, Alice S ^a   Paffenbarger, Ralph S ^a   Sarles, Dorien L ^a   Kampert, James B ^a   Grosser, Stella ^a   Jung, Dexter L ^a   Ballon, Samuel ^b   Hendrickson, Michael ^a   Mohle boetani, Janet ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Contraceptives; Menarche; Menopause; Oral; Ovarian neoplasms; Ovulation; Parity

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; CONTROLLED STUDY; ETHNIC OR RACIAL ASPECTS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; OVARY CARCINOMA; OVULATION; PARITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

AGE FACTORS; AMERICAS; BIOLOGY; CALIFORNIA; CANCER; CONTRACEPTION; CONTRACEPTIVE METHODS; CONTROL GROUPS; DATA ANALYSIS; DATA COLLECTION; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; FAMILY PLANNING; FERTILITY; FERTILITY MEASUREMENTS; MEASUREMENT; MENOPAUSE; MENSTRUATION; NEOPLASMS; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES; OVARIAN CANCER; PARITY; POPULATION; POPULATION CHARACTERISTICS; POPULATION DYNAMICS; PREVALENCE; REPRODUCTION; RESEARCH METHODOLOGY; RISK FACTORS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CONTRACEPTIVES, ORAL; EPIDEMIOLOGIC METHODS; FEMALE; HUMAN; MENARCHE; MENOPAUSE; MIDDLE AGE; OVARIAN NEOPLASMS; OVULATION; PARITY; RISK FACTORS;

EID: 0024260877     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a115076     Document Type: Article

References (44)

1. Annegers JF, Strom H, Decker DG, et al. Ovarian cancer: incidence and case-control study. Cancer 1979;43:723-9.
2. Casagrande JT, Louie EW, Pike MC, et al. "Incessant ovulation" and ovarian cancer. Lancet 1979;2:170-3.
3. Cramer DW, Hutchison GB, Welch GR, et al. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. JNCI 1983;71:711-16.
4. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. The reduction in risk of ovarian cancer associated with oral contraceptive use. N Engl J Med 1987;316:650-5.
5. Cramer DW, Hutchison GB, Welch WR, et al. Factors affecting the association of oral contraceptives and ovarian cancer. N Engl J Med 1982;307:1047-51.
6. Demopoulos RI, Seltzer V, Dubin N, et al. The association of parity and marital status with the development of ovarian carcinoma: clinical implications. Obstet Gynecol 1979, 54:150-5.
7. Franceschi S, La Vecchia C, Helmrich SP, et al. Risk factors for epithelial ovarian cancer in Italy. Am J Epidemiol 1982;115:714-19.
8. Hildreth NG, Kelsey JL, LiVolsi VA, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981;114:398-405.
9. Joly DJ, Lilienfeld AM, Diamond EL, et al. An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am J Epidemiol 1974;99:190-209.
10. La Vecchia C, Franceschi S, Gallus G, et al. Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol 1983;12:161-4.
11. McGowan L, Parent L, Lednar W, et al. The woman at risk for developing ovarian cancer. Gynecol Oncol 1979;7:325-44.
12. Nasca PC, Greenwald P, Chorost S, et al. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984;119:705-13.
13. Newhouse ML, Pearson RM, Fullerton JM, et al. A case control study of carcinoma of the ovary. Br J Prev Soc Med 1977;31:148-53.
14. Rosenberg L, Shapiro S, Slone D, et al. Epithelial ovarian cancer and combination oral contraceptives. JAMA 1982;247:3210-12.
15. Weiss NS, Lyon JL, Liff JM, et al. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer 1981;28:669-71.
16. Willett WC, Bain C, Hennekens CH, et al. Oral contraceptives and risk of ovarian cancer. Cancer 1981;48:1684-7.
17. Fathalla MF. Incessant ovulation—a factor in ovarian neoplasia? (Letter). Lancet 1971;2:163.
18. Fathalla MF. Factors in the causation and incidence of ovarian cancer. Obstet Gynecol Surv 1972;27:751-68.
19. Horme JW, Asire AJ, Young JL, et al.,. SEER program. Cancer incidence and mortality in the United States, 1973-81.
20. Bethesda, MD: National Cancer Institute, 1985. (NIH publication no. 85- 1837). 20.
21. Fasal E, Paffenbarger RS. Oral contraceptives as related to cancer and benign lesions of the breast. JNCI 1975;55:767-73.
22. Paffenbarger RS, Kampert JB, Chang H-G. Characteristics that predict risk of breast cancer before and after the menopause. Am J Epidemiol 1980;112:258-68.
23. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. (IARC scientific publication no. 32). Lyon: IARC, 1980.
24. Mauritsen R. EGRET software program. Seattle, WA: Statistics and Epidemiology Research Corporation, 1986.
25. Thomas DC. General relative risk models for matched case-control and failure time analysis. Biometrics 1981;37:673-8.
26. Perez A, Vela P, Masnick GS, et al. First ovulation after childbirth: the effect of breast-feeding. Am J Obstet Gynecol 1972;114:1041-7.
27. Gray R, Eslami S, Campbell O. Return of fertility during lactation monitored by uninary steroid assays. (Abstract). Am J Epidemiol 1987;126:761.
28. Speroff L, Glass RH, Kase WG, eds. Clinical gynecologic endocrinology and infertility. 3rd ed. Baltimore: Williams & Wilkins, 1984:249-50.
29. Miller AB, Barclay THC, Choi NW, et al. A study of cancer, parity and age at first pregnancy. J Chronic Dis 1980, 33:595-605.
30. Beral V, Fraser P, Chilvers C. Does pregnancy protect against ovarian cancer? Lancet 1978;1: 1083-6.
31. Risch HA, Weiss NS, Lyon JL, et al. Events of reproductive life and the incidence of epithelial ovarian cancer. Am J Epidemiol 1983;117:128-39.
32. Byers T, Marshall J, Graham S, et al. A casecontrol study of dietary and nondietary factors in ovarian cancer. JNCI 1983;71:681-6.
33. Wynder EL, Dodo H, Barber HRK. Epidemiology of cancer of the ovary. Cancer 1969;23:352-70.
34. Voigt LF, Harlow BL, Weiss NS. The influence of age at first childbirth and parity on ovarian cancer risk. Am J Epidemiol 1986;124:490-1.
35. Lesher L, McGowan L, Hartge P, et al. Age at first birth and risk of epithelial ovarian cancer. JNCI 1985;74:1361-2.
36. La Vecchia C, Decarli A, Franceschi S, et al. Age at first birth and the risk of epithelial ovarian cancer. JNCI 1984;73:663-6.
37. Tzonou A, Day NE, Trichopoulos D, et al. The epidemiology of ovarian cancer in Greece: a casecontrol study. Eur J Cancer Clin Oncol 1984; 20:1045-52.
38. Mohle J, Whittemore AS, Pike M, et al. Gonadotrophins and ovarian cancer risk. (Letter). JNCI 1985;75:178-9.
39. Stadel BV. The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 1975;123:772-4.
40. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. JNCI 1983;71:717-21.
41. Schiff I. The effects of conjugated estrogens on gonadotrophins. Fertil Steril 1980;33:333-4.
42. Parlow AF, Daane TA, Dignam WJ. On the concentration of radioimmunoassayable FSH circulating in blood throughout human pregnancy. J Clin Endocrinol Metab 1970;31:213-14.
43. Hoover R, Gray LA Sr, Fraumeni JF Jr. Stilboestrol (diethylstilbestrol) and the risk of ovarian cancer. Lancet 1977;1:533-4.
44. Weiss NS, Lyon JL, Krishnamurthy S, et al. Noncontraceptive estrogen use and the occurrence of ovarian cancer. JNCI 1982;68:95-8.